Curemark Competitors and Similar CompaniesClear all
PaxMedica's competitors and similar companies include Synthorx.
 PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | |
Founding Date | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tarrytown, US HQ | Locations San Diego, US HQ |
Employees | Employees 2100% increase | Employees 3939% increase |
Valuation ($) | Valuation ($) 1.1 m | Valuation ($) 2.2 b |
Financial | ||
Net income | Net income ($18.3m) (FY, 2023) | Net income ($5.9m) (FY, 2017) |
For sources of this data, please see the company profile
View Company Profiles
Synthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company